InGeneron believes that evidence-based regenerative therapy will redefine the health care experience. Our system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells.

InGeneron is a cell therapy company that enables novel, evidence-based treatments designed to heal certain chronic conditions using a patient’s own regenerative cells processed at the bedside for same-day application. We produce a platform of medical devices that process adipose (body fat) tissue and rapidly and efficiently isolate adipose-derived regenerative cells (ADRCs) to be reintroduced into the patient.

The ADRCs, also known as Stromal Vascular Fraction, include mesenchymal stem cells, which are able to differentiate into

multiple cell types and therefore replace and heal damaged tissue. Multiple studies show that ADRCs can be effective in treating a variety of soft tissue and bone conditions and have a high safety profile [1-7].

Our advanced cell technologies have the potential to help physicians treat a wide range of diseases and injuries. Our initial focus is to help patients who suffer from chronic pain and a reduced quality of life as a result of musculoskeletal indications.